HTR6 and Alzheimer disease: Interestingly, another serotonin GPCR, the serotonergic subtype 6 receptor (5-HT6R) appears as a valuable target to treat cognitive impairments in the field of neurodegenerative disorders, notably AD (Karila et al., 2015).